Curis | CRIS - Ebit





Ebit Veränderung Datum
Alaunos Therapeutics USD -952K 60K 2026-06
Amgen USD 4.68B 65M 2026-09
AstraZeneca USD 4.66B 1.5B 2026-09
Bayer EUR 129M 626M 2026-09
Bristol-Myers Squibb USD 255M 44M 2026-09
CSL USD 2.64B 116M 2025-12
Curis USD -11.52M 3.64M 2026-03
Eli Lilly USD 13.09B 635M 2026-09
Exelixis USD 268.42M 20.01M 2026-09
Gilead Sciences USD 3.85B 1.17B 2026-06
GlaxoSmithKline GBP 2.86B 251M 2026-09
Incyte USD -707.47M 1.41B 2026-09
Merck USD 7.33B 6.49B 2026-09
Novartis USD 5.14B 411M 2026-09
Pfizer USD 4.85B 5.03B 2026-09
Roche Holding CHF 11.46B 1.91B 2026-06
Sanofi EUR 4.72B 3.6B 2026-09
Takeda JPY 205.32B 3.9B 2026-09
TG Therapeutics USD 21.67M 13.12M 2026-06
Verastem USD -44.9M 3.42M 2026-03